CCDC50 anticorps (Middle Region)

N° du produit ABIN631775

L’anticorps anti-CCDC50 Polyclonal Lapin est utilisé pour la détection de CCDC50 dans des échantillons de Humain. Il a été validé pour WB.

Aperçu rapide pour CCDC50 anticorps (Middle Region) (ABIN631775)

Antigène: CCDC50 (Coiled-Coil Domain Containing 50 (CCDC50))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CCDC50 est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-CCDC50 anticorps

Épitope: Middle Region

Specificité: CCDC50 antibody was raised against the middle region of CCDC50

Purification: Affinity purified

Immunogène: CCDC50 antibody was raised using the middle region of CCDC50 corresponding to a region with amino acids KAKEREKSSLDKRKQDPEWKPKTAKAANSKSKESDEPHHSKNERPARPPP

Information d'application

Indications d'application: WB: 1 µg/mL
Optimal conditions should be determined by the investigator.

Commentaires:

CCDC50 Blocking Peptide, (ABIN939634), is also available for use as a blocking control in assays to test for specificity of this CCDC50 antibody

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Lyophilized powder. Add distilled water for a 1 mg/mL concentration of CCDC50 antibody in PBS

Concentration: Lot specific

Buffer: PBS

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.

Détails sur CCDC50

Antigène: CCDC50 (Coiled-Coil Domain Containing 50 (CCDC50))

Autre désignation: CCDC50

Sujet: CCDC50 is a soluble, cytoplasmic, tyrosine-phosphorylated protein with multiple ubiquitin-interacting domains. Mutations in this gene cause nonsyndromic, postlingual, progressive sensorineural DFNA44 hearing loss. In mouse, the protein is expressed in the inner ear during development and postnatal maturation and associates with microtubule-based structures. This protein may also function as a negative regulator of NF-kB signaling and as an effector of epidermal growth factor (EGF)-mediated cell signaling.

Poids moléculaire: 56 kDa (MW of target protein)